Clearmind Medicine Inc. Depreciation Expense
Clearmind Medicine Inc. (CMND) reported Depreciation Expense of $38.41 thousand for the 12-month period ending 2025-10-31, per its 20-F filed 2026-01-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DepreciationExpense · last filed 2026-01-20
CAD
| Period end | Depreciation Expense 12 month |
|---|---|
| 2022-10-31 | 82.80K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Depreciation Expense 12 month |
|---|---|
| 2025-10-31 | $38.41K 20-F · filed 2026-01-20 |
| 2024-10-31 | $39.02K 20-F · filed 2026-01-20 |
| 2023-10-31 | $35.38K 20-F/A · filed 2024-03-18 |